Search results
Janet Woodcock. Janet Woodcock (born August 29, 1948) is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA). [2] She joined the FDA in 1986, and has held a number of senior leadership positions there, including terms as ...
- Roger Miller
- Robert Califf
Feb 17, 2022 · She served as the Acting Commissioner of Food and Drugs from Jan. 20, 2021 until Feb. 17, 2022. Dr. Woodcock began her FDA career in 1986 at the Center for Biologics Evaluation and Research (CBER ...
- Principal Deputy Commissioner
- Office of The Commissioner
Jan 20, 2021 · Janet Woodcock was named Acting Commissioner of Food and Drugs on January 20, 2021. As Acting Commissioner, Dr. Woodcock oversees the full breadth of the FDA portfolio and execution of the Federal Food, Drug, and Cosmetic Act and other applicable laws. This includes assuring the safety, effectiveness, and security of human and veterinary drugs ...
Jan 29, 2024 · This Wednesday will be Dr. Janet Woodcock’s last day at the US Food and Drug Administration (FDA), capping a remarkable 38-year career at the agency. She’s been called one of the most powerful and influential drug regulators worldwide. Last Thursday, Focus sat down with Woodcock in her office at FDA’s White Oak campus, where she reflected ...
Nov 30, 2023 · For almost 40 years, Janet Woodcock has provided leadership across the entire spectrum of FDA regulation. Her retirement was inevitable — there has been speculation every year for the past decade — but now it’s real. It has been officially announced that she will retire from federal service in early 2024.
Jan 30, 2024 · Janet Woodcock joined the FDA’s biologics division in 1986 but soon moved to the drug side, where over nearly three decades, she oversaw hundreds of reviews, new and evolving classes of ...
Nov 16, 2023 · U.S. Food and Drug Administration (FDA) Principal Deputy Commissioner Dr. Janet Woodcock, who led the regulator during the height of the COVID-19 pandemic as acting chief, plans to retire early ...
